Pulmocide halts Phase 3 trial of Opelconazole in severe lung infection
The decision follows an interim analysis conducted when roughly half of the patients had completed their Day 84 visit
The decision follows an interim analysis conducted when roughly half of the patients had completed their Day 84 visit
Subscribe To Our Newsletter & Stay Updated